Managed the PR strategy for a global genomics service company’s launch, initial public offering, and acquisition in four years.
Clinical Trials
Partnered with pharma, research, and academic organizations in the US, UK, and South Africa to communicate technological progress with a tuberculosis candidate vaccine. Activities included context setting for an unsuccessful Phase 2 clinical trial.
Pharmaceuticals
Created a global communications academy for research and executive staff at a top 10 pharma company, administered the program, and taught classes.
Rare Diseases
Represented an orphan drug while its biologics license application was submitted to the U.S. Food and Drug Administration and withdrawn twice.